Submicron Crystals of the Parkinson’s Disease Substantia nigra: Calcium Oxalate, Titanium Dioxide and Iron Oxide
Abstract
Parkinsons disease (PD) results of the death of dopaminergic neurons of the substantia nigra. When activated, the NLRP3 inflammasome of phagocytes releases inflammatory agents, their release resulting in the death of proximal cells. The hallmark protein of PD, aggregated -synuclein, is phagocytized and activates the NLRP3 inflammasome. Because crystalline particles are known to activate the NLRP3 inflammasome, to enhance -synuclein expression and aggregation in dopaminergic neurons and because their facets may mis-template adsorbed -synuclein, we probe here, by transmission electron microscopy (TEM), four human PD substantia nigra specimens for their crystalline particles. Samples weighing 5 mg of PD stages 1, 2, 4 and 5 were processed by proteolysis and centrifugation. TEM-grids were dipped in the centrifugate diluted to 1 mL and the dried films were searched for crystalline particles. Two types of crystalline particles, known to activate the NLRP3 inflammasome were found. Endogenous calcium oxalate, a downstream product of ascorbate and dopamine oxidation-produced hydrogen peroxide; and TiO2, the with pigment of foods and medications. The number-density of the NLRP-inflammasome activating crystalline particles found approached the reported about-equal number-densities of microglia and neuronal cells in the brain.\n\nThe observations of COD and protein-coated TiO2 support two putative feedback loops, both leading to dopaminergic neuron death. In one, polymeric oxidized-dopamine catalyst accelerates H2O2-generation, the H2O2 indirectly oxidizing ascorbate in an ascorbate-fueled, oxalate-generating, loop the excess oxalate precipitating the subsequently inflammasome-activating COD crystals; In the second, protein-adsorbing facets of TiO2 mis-template the aggregation of -synuclein to produce inflammasome-activating mis-folded -synuclein.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathologic α-Synuclein-NOD2 Interaction and RIPK2 Activation Drives Microglia-Induced Neuroinflammation in Parkinson's Disease
Bo Am Seo, Seung‐Hwan Kwon, … Han Seok Ko·bioRxiv·Feb 19, 2024
- PODXL regulates the neuronal entry of α-synuclein aggregates
Sandesh Neupane, Lea Šustić, … Adriano Aguzzi·bioRxiv·Oct 21, 2026
- Paraquat Licences α-Synuclein to Trigger NLRP3-Dependent Pyroptosis in Microglia
Yuzhihan Cao, Vandana Deora, … Eduardo A. Albornoz·bioRxiv·Jul 23, 2025
- Alpha-synuclein and neuromelanin converge to promote Parkinsons disease pathology
Alba Nicolau, Marta González-Sepúlveda, … Miquel Vila·bioRxiv·Oct 24, 2026
- The interplay between CB2 and NMDA receptors in Parkinsons disease
Jaume Lillo, Iu Raïch, … Irene Reyes‐Resina·bioRxiv·Jan 20, 2025
- KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's Disease
Manikandan Samidurai, Karthick Chennakesavan, … Arthi Kanthasamy·bioRxiv·Mar 18, 2025